Bjørn H Ebdrup
Mental Health Center Glostrup, Center for Neuropsychiatric Schizophrenia Research · University of Copenhagen
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bjørn H Ebdrup as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:09 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06743711 · Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind ProjectBjorn H. Ebdrup · recruiting · Severe Mental Illness, Schizophrenia Spectrum &Amp; Other Psychotic Disorders, Bipolar Affective Disorder · study director
- Ph2NCT03994965 · The Sub-Sero StudyBjorn H. Ebdrup · withdrawn · Schizophrenia, Psychosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:10 UTC. The ranking covers the 200 most relevant of 23 PubMed records, and a shared surname and initials can bring in a namesake. All 23 on PubMed
- Haloperidol for the Treatment of Delirium in ICU Patients.N Engl J Med · 2022136 citationsRCR 13.2
- Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.Diabetes Obes Metab · 201790 citationsRCR 3.8
- Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms.Int J Neuropsychopharmacol · 201169 citationsRCR 2.3
- No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia.Acta Psychiatr Scand · 201745 citationsRCR 1.9
- P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment.Schizophr Bull · 201344 citationsRCR 1.8
- Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine.Psychopharmacology (Berl) · 201140 citationsRCR 1.5
- Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.Transl Psychiatry · 201735 citationsRCR 1.7
- Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients.Psychol Med · 201928 citationsRCR 1.7
- Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra-high risk for psychosis.Hum Brain Mapp · 201928 citationsRCR 1.6
- 25 citationsRCR 1.5